| Judd Alan Durrant, | |
|
3250 S Eagle Rd, Meridian, ID 83642-7018 | |
| (208) 898-2543 | |
| Not Available |
| Full Name | Judd Alan Durrant |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3250 S Eagle Rd, Meridian, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023517588 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 7791 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Judd Alan Durrant, 3250 S Eagle Rd, Meridian, ID 83642-7018 Ph: (208) 898-2543 | Judd Alan Durrant, 3250 S Eagle Rd, Meridian, ID 83642-7018 Ph: (208) 898-2543 |
News Archive
Laboratory Corporation of America® Holdings today announced the successful completion of its acquisition of Genzyme Genetics, a business unit of Genzyme Corp., in an all cash transaction valued at $925 million. Net of expected income tax benefits, less acquisition-related expenses, the acquisition has a net cash cost to LabCorp of approximately $795 million.
"Rather than asking whether the Patient Protection and Affordable Care Act does everything to improve access and lower costs, we should ask how it compares with the status quo," the American College of Physicians' senior public policy adviser said in a paper published online today in Annals of Internal Medicine, the flagship journal of ACP.
Physicians are anticipating the arrival of new oral therapies for multiple sclerosis patients, with initial research showing very high awareness of oral candidates, particularly Novartis' Gilenya, which received FDA approval for relapsing forms of the disease in late September. The majority of neurologists expect Gilenya to be very useful as a therapy and trial of the drug is predicted to be strong, according to new research by GfK HealthCare.
In a recently released Patient Safety E-lert, the ECRI Institute Patient Safety Organization (PSO) highlights a patient safety issue involving cardiac monitoring of incorrect patients. The issue was brought to ECRI Institute PSO's attention in its analysis of reports submitted by participating healthcare providers.
MedTera, an integrated marketing solutions company dedicated to improving education, promotion and communications in the healthcare, life sciences and pharmaceutical industries, today announced results of a survey of more than 7,000 patients about the need for better disease management education.
› Verified 5 days ago
Michael J Griffiths, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 520 S Eagle Rd, Meridian, ID 83642 Phone: 208-706-5255 Fax: 208-706-5253 | |
Mark Smith, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 N Main St, Meridian, ID 83642 Phone: 208-888-7311 | |
Gordon Riley Melvin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1570 E Fairview Ave, Meridian, ID 83642 Phone: 208-888-0034 | |
Mrs. Audrey Gyung Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 520 S Eagle Rd, Meridian, ID 83642 Phone: 208-706-1523 Fax: 208-706-1543 | |
Jennifer Campbell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1570 E Fairview Ave, Meridian, ID 83642 Phone: 208-888-0034 Fax: 208-887-1332 | |
Kohner Warren, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1400 W Chinden Blvd, Meridian, ID 83646 Phone: 208-893-6033 |